Marina Bobkova

Prof. Dr. Marina Bobkova

Ivanovsky Institute of Virology, Gamaleya National Research Center for Epidemiology and Microbiology, Russian Ministry of health, 123098 Moscow, Russia
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2004 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
ABAleksei F. Bobkov
Aleksei F. Bobkov
EKElena V. Kazennova
Elena V. Kazennova
LSLudmila M. Selimova
Ludmila M. Selimova
TKTatyana A. Khanina
Tatyana A. Khanina
GRGrigory S. Ryabov
Grigory S. Ryabov
VPVadim V. Pokrovsky
Vadim V. Pokrovsky

10 February 2001 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
ABAleksei Bobkov
Aleksei Bobkov
EKElena Kazennova
Elena Kazennova
TKTatyana Khanina
Tatyana Khanina
MBMarina Bobkova
Marina Bobkova
LSLudmila Selimova
Ludmila Selimova
JWJonathan Weber
Jonathan Weber
An explosive epidemic of human immunodeficiency virus type 1 (HIV-1) has been documented among injecting drug users (IDUs) in the former Soviet Union republics. In 1999, the two largest local IDU outbreaks of HIV-1 infection in the Russian Federation were registered in the Moscow and Irkutsk regions, where 13,004 HIV-1 cases were identified (44% of the total number of HIV-1 infections in Russia in 1999). To study the prevailing genetic variants and to estimate the genetic diversity of HIV-1 in these outbreaks, 60 samples from Moscow (n = 36) and from Irkutsk (n = 24) were analyzed using the gag/env heteroduplex mobility assay, and the env gp120 V3 encoding regions obtained from 23 individuals were sequenced. Both virus populations were highly homogeneous (the means of pairwise nucleotide distance were 1.75 ± 0.83 and 2.35 ± 1.59 for Irkutsk and Moscow, respectively), and similar to the subtype A viruses obtained earlier from IDUs in the former Soviet Union. The subtype A HIV-1 variant thus dominates in the largest HIV-1 outbreaks among IDUs in the Russian Federation.

2 July 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
MMMafalda Miranda
Mafalda Miranda
MPMarta Pingarilho
Marta Pingarilho
VPVictor Pimentel
Victor Pimentel
MMMaria Rosario Martins
Maria Rosario Martins
AVAnne-Mieke Vandamme
Anne-Mieke Vandamme
AAAna Abecasis
Ana Abecasis
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm3 or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population.

1 September 2002 in Journal of General Virology
Verified
Journal Article
Closed access
MBMarina Bobkova
Marina Bobkova
PSProf. Dr. Jörn Stitz
Prof. Dr. Jörn Stitz
MEMartin Engelstädter
Martin Engelstädter
KCKlaus Cichutek
Klaus Cichutek
CBChristian J. Buchholz
Christian J. Buchholz
Activation of the murine leukaemia virus (MLV) envelope protein (Env) requires proteolytic cleavage of the R-peptide, a 16 amino acid C-terminal part of the cytoplasmic tail (C-tail) of Env. This paper demonstrates the presence of R-peptides in Env proteins of C-type retroviruses of simian, avian and porcine origin. Sequence alignment with the MLV C-tail led to the identification of a conserved hydrophobic protease cleavage motif located in the centre of retroviral Env protein C-tails. Expression of Env proteins, truncated at the predicted cleavage sites, of spleen necrosis virus (SNV), gibbon ape leukaemia virus and porcine endogenous retroviruses resulted in cell–cell fusion as monitored by microscopy and reporter gene fusion assays. Western blot analysis of MLV particles pseudotyped with the SNV Env protein demonstrated proteolytic cleavage of the SNV R-peptide by the MLV protease. Our data suggest that activation of membrane fusion by R-peptide cleavage is a common mode in C-type retroviruses.

15 November 2017 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ILIlya Lapovok
Ilya Lapovok
ALAlexey Lopatukhin
Alexey Lopatukhin
DKDmitry Kireev
Dmitry Kireev
ЕКЕ. В. Казеннова
Е. В. Казеннова
ALAleksey Lebedev
Aleksey Lebedev
VPV. V. Pokrovsky
V. V. Pokrovsky
Aim. To simultaneously analyze HIV-1 samples from all Russian regions to characterize the epidemiology of HIV infection in the country as a whole. Subjects and methods. The most extensive study was conducted to examine nucleotide sequences of the pol gene of HIV-1 samples isolated from HIV-positive persons in different regions of Russia, with the diagnosis date being fixed during 1987—2015. The nucleotide sequences of the HIV-1 genome were analyzed using computer programs and on-line applications to identify a virus subtype and new recombinant forms. Results. The nucleotide sequences of the pol gene were analyzed in 1697 HIV-1 samples and the findings were that the genetic variant subtype A1 (IDU-A) was dominant throughout the entire territory of Russia (in more than 80% of all infection cases). Other virus variants circulating in Russia were analyzed; the phenomenon of the higher distribution of the recombinant form CRF63/02A in Siberia, which had been previously described in the literature, was also confirmed. Four new recombinant forms generated by the virus subtype A1 (IDU-A) and B and two AG recombinant forms were found. There was a larger genetic distance between the viruses of IDU-A variant circulating among the injecting drug users and those infected through heterosexual contact, as well as a change in the viruses of subtype G that caused the outbreak in the south of the country over time in 1988—1989. Conclusion. The findings demonstrate continuous HIV-1 genetic variability and recombination over time in Russia, as well as increased genetic diversity with higher HIV infection rates in the population.

13 November 2014 in AIDS
Verified
Journal Article
Closed access
AKAnna N. Kolomeets
Anna N. Kolomeets
VVVici Varghese
Vici Varghese
PLPhilippe Lemey
Philippe Lemey
MBMarina Bobkova
Marina Bobkova
Robert W ShaferRobert W Shafer
Robert W Shafer
Background: The subtype A variant in the Former Soviet Union (AFSU) causes most of Russia's HIV-1 infections. However, the spectrum of drug-resistance mutations (DRMs) in antiretroviral experienced patients with this variant has not been studied. Methods: Between 2010 and 2013, genotypic resistance testing was performed on plasma samples from 366 antiretroviral-experienced patients in Siberia. Results: Three-hundred patients (82%) had subtype AFSU and 55 (15%) had CRF02_AG viruses. The pattern of DRMs was consistent with patient antiretroviral history with one exception. G190S was the most common nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance mutation, occurring in 55 (33%) subtype AFSU viruses from 167 NNRTI-experienced patients compared with none of 37 CRF02_AG viruses from NNRTI-experienced patients (P < 0.001). The next most common subtype AFSU NNRTI-resistance mutation, K103N, occurred in 25 (15%) viruses. Wild-type glycine (G) at position 190 is encoded by GGC in more than 99% of published AFSU strains. By contrast, G190 is encoded by GGA or GGG in 97% of other subtypes and in subtype A strains outside of the FSU. Therefore, G190S results from a single G→A transition: G (GGC) → S (AGC) almost exclusively in subtype AFSU viruses. Conclusion: The predisposition of subtype AFSU to G190S is concerning because G→A is the most common HIV-1 mutation and because G190S causes higher levels of nevirapine and efavirenz resistance than K103N. This study exemplifies the need for characterizing the genetic mechanisms of resistance in diverse populations and warrants studies to verify that NRTI/NNRTI regimens are as efficacious in treating subtype AFSU as viruses belonging to other subtypes.